These authors contributed equally to this work.
Polypeptide chain release factor eRF3 is a novel molecular partner of survivin
Article first published online: 4 FEB 2013
© 2013 International Federation for Cell Biology
Cell Biology International
Volume 37, Issue 4, pages 359–369, April 2013
How to Cite
Xiao, R., Gao, Y., Shen, Q., Li, C., Chang, W. and Chai, B. (2013), Polypeptide chain release factor eRF3 is a novel molecular partner of survivin. Cell Biology International, 37: 359–369. doi: 10.1002/cbin.10043
- Issue published online: 11 MAR 2013
- Article first published online: 4 FEB 2013
- Accepted manuscript online: 17 JAN 2013 04:18AM EST
- Manuscript Accepted: 7 JAN 2013
- Manuscript Received: 31 OCT 2012
- cellular localisation;
- interaction map;
The eukaryotic class II polypeptide chain release factor (eRF3) is an eRF1- and ribosome-dependent GTPase involved in translation termination of protein biosynthesis. eRF3 is a multifunctional protein that is also involved in chromosomal segregation and cytokinesis during mitosis. Survivin is a member of the inhibitor of apoptosis protein (IAP) family that is involved in the organisation of spindle and cell apoptosis. Interaction between survivin and eRF3a-F3 or eRF3b, encoded by the GSPT1 and GSPT2 genes, respectively, was confirmed using yeast two-hybrid (Y2H) and pull-down assays in vitro, and co-immunoprecipitation in vivo. The domains involved in the formation of the survivin–eRF3s complex have been identified. The sites on survivin that interact with eRF3 are located in the baculovirus IAP repeat domain (residues 65–76), which forms a beta-strand structure with an overall negative charge. The sites on eRF3 that interact with survivin were localised to the N-terminal domain(NTD; residues 131–200). Cell localisation experiments indicate that both factors are in the nucleus, suggesting that they cooperatively function in nuclear processes.